Back to BLTE

Affinity Asset Advisors, LLC → BLTE

Affinity Asset Advisors, LLC BLTE Position History

Belite Bio, Inc • Healthcare

Quarters held
4
Latest value
$41.1M
Q3 2026
Peak value
$41.1M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$3.2M
Q1 2026$10.4M
Q2 2026$25.4M
Q3 2026$41.1M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$41.1M242.1K——
Q2 2026$25.4M165.0K——
Q1 2026$10.4M65.0K——
Q4 2025$3.2M20.0K——

Other funds holding BLTE

Other Affinity Asset Advisors, LLC positions

ROIV

ROIVANT SCIENCES LTD

$132.7M
APGE

APOGEE THERAPEUTICS INC

$131M
ROIV

ROIVANT SCIENCES LTD

$117M
SYRE

SPYRE THERAPEUTICS INC

$113.9M
SYRE

SPYRE THERAPEUTICS INC

$113.6M
APGE

APOGEE THERAPEUTICS INC

$108.2M
XENE

XENON PHARMACEUTICALS INC

$97.4M
XENE

XENON PHARMACEUTICALS INC

$96.3M